September 28, 2012
1 min read
Save

Elevated rheumatoid factor levels increased long-term risk for RA

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healthy individuals with elevated plasma levels of the antibody rheumatoid factor had up to a 26-fold greater long-term risk for developing rheumatoid arthritis than those with normal levels in a prospective study.

Researchers in Denmark measured baseline plasma levels of IgM rheumatoid factor in 9,712 white Danish participants (52% women), aged 20 to 100 years, without diagnoses of rheumatoid arthritis (RA). The cohort, part of the Copenhagen City Heart Study, was divided into groups: participants with elevated rheumatoid factor levels of 25 to 50 IU/mL (n=176), 50.1 to 100 IU/mL (n=187), and greater than 100 IU/mL (n=55). They were compared with participants with normal levels of less than 25 IU/mL (n=9,294).

In a 28-year follow-up from 1981 to August 2010, 183 participants developed RA during 187,654 person-years. Researchers found that a doubling of rheumatoid factor level resulted in a statistically significant, multivariable-adjusted HR of 3.3 for developing RA (95% CI, 2.7-4.0). Risk for other autoimmune rheumatic diseases, including Sjögren’s syndrome (HR=1.8; 95% CI, 0.8-4.1), systemic lupus erythematosus (HR=2.5; 95% CI, 0.9-6.6) and systemic sclerosis (HR=3.1; 95% CI, 1.0-9.3), also showed similar trends that reached near significance.

Participants with rheumatoid factor levels of greater than 100 IU/mL were associated with a 26-fold increased risk for developing RA (HR=26; 95% CI, 15-46) compared with those with normal levels. Researchers said the highest absolute 10-year risk for RA was 32% and occurred in women aged 50 to 69 years who ever smoked and had rheumatoid factor levels greater than 100 IU/mL.

Although their study did not prove a causal relationship between rheumatoid factor levels and the pathogenesis of RA development, researchers concluded, “these novel findings may lead to revision of guidelines for early referral to a rheumatologist and early arthritis clinics based on rheumatoid factor testing.”